The use of radiosynovectomy in patients with juvenile idiopathic arthritis. Assessment of treatment efficacy and safety

被引:0
|
作者
Gazda, Agnieszka [1 ]
Cwikla, Jaroslaw [2 ]
Kotodziejczyk, Beata [1 ]
Szczygielska, Izabela [1 ]
Hernik, Elzbieta [1 ]
Gietka, Piotr [1 ]
Rutkowska-Sak, Lidia [1 ]
机构
[1] Natl Inst Geriatr Rheumatol & Rehabil, Clin Dev Age Rheumatol, 1 Spartanska St, PL-02637 Warsaw, Poland
[2] Gammed Diagnost & Treatment Ctr, Warsaw, Poland
来源
REUMATOLOGIA | 2021年 / 59卷 / 04期
关键词
Intraarticular injection; Juvenile idiopathic arthritis; Local treatment; Radiosynovectomy;
D O I
10.5114/reum.2021.108450
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The aim of the study was to evaluate the usefulness of knee joint radiosynovectomy (RS) in patients suffering from juvenile idiopathic arthritis (JIA). Material and methods: One hundred RS procedures performed in 58 patients with JIA in average age 10.4 years were evaluated. Results: After 6 weeks, a decrease in the number of cases with joint pain from 90.3% to 29%, with joint oedema from 100% to 74.5%, with joint exudate from 100% to 60.6%, with gait disorders from 19.4% to 3.2%, with joint mobility disorders from 51.1% to 26.6% in the RS cases was observed. A reduction of the score in the Colorado scale from 10.9 to 4.66, in the pain visual analogue scale (VAS) from 50 to 10, in the illness VAS assessed by the patient/parent from 69.9 to 32.4, in the illness VAS assessed by the physician from 68.8 to 36.9 was observed. Six months after the RS procedure, a reduction in the number of cases with joint pain from 89.5% prior to the procedure to 29.5%, with oedema from 100% to 58.3%, with exudate from 100% to 46.9%, with gait disorders from 20% to 2.1%, with joint motility disorders from 51.1% to 26.1% was achieved. The score in the Colorado scale was reduced from 10.9 to 4.04, in the pain VAS from 40 to 0, in the illness VAS assessed by the patient/parent from 69.7 to 27.9, in the illness VAS assessed by the physician from 68.8 to 32.4. In ultrasound examinations, the greatest improvement compared to the initial condition was recorded in the 6th month after the RS. Radiosynovectomy was positively evaluated by parents and patients in 34 anonymous surveys. Early and late observations (average 1473 days) did not show lesions at the isotope injection site, and no neoplastic lesions were observed. Conclusions: Radiosynovectomy is a valuable therapeutic option for local treatment in patients with JIA.
引用
收藏
页码:219 / 229
页数:11
相关论文
共 50 条
  • [1] Safety and Efficacy of Tocilizumab Treatment In Children with Systemic Juvenile Idiopathic Arthritis.
    Alexeeva, Ekaterina
    Denisova, Rina
    Valieva, Saniya
    Bzarova, Tatyana
    Isayeva, Kseniya
    Sleptsova, Tatyana
    Mitenko, Elena
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S109 - S109
  • [2] TNF ALFA blocking treatment in adult patients with juvenile idiopathic arthritis. Clinical efficacy and safety
    Jarosova, K
    Svihalek, J
    Dusek, L
    Vencovsky, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 384 - 384
  • [3] EFFICACY AND SAFETY OF SECUKINUMAB TREATMENT IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS
    Kriulin, I.
    Alexeeva, E.
    Dvoryakovskaya, T.
    Isaeva, K.
    Chomakhidze, A.
    Chistyakova, E.
    Lomakina, O.
    Denisova, R.
    Mamutova, A.
    Fetisova, A.
    Gautier, M.
    Vankova, D.
    Krekhova, E.
    Shingarova, M.
    Alshevskaya, A.
    Moskalev, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 485 - 485
  • [4] Efficacy and safety of rituximab in patients with juvenile idiopathic arthritis
    Alexeyeva, E. I.
    Bzarova, T. M.
    Valiyeva, S. I.
    Isayeva, K. B.
    Chomakhidze, A. M.
    Akulova, S. S.
    Amital, H.
    Lisitsyn, A. O.
    Denisova, R. V.
    Gudkova, E. Y.
    ACTA PAEDIATRICA, 2008, 97 : 69 - 70
  • [5] Efficacy and safety of switching etanercept to an anti-TNF monoclonal antibody in patients with juvenile idiopathic arthritis.
    Russo, Ricardo A.
    Katsicas, Maria M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S681 - S682
  • [6] Infliximab in the treatment of refractory juvenile idiopathic arthritis.
    Masatlioglu, S
    Gogus, F
    Cevirgen, D
    Seyahi, E
    Hatemi, G
    Ozdogan, H
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S481 - S481
  • [7] Cytokines and juvenile idiopathic arthritis.
    Woo P.
    Current Rheumatology Reports, 2002, 4 (6) : 452 - 457
  • [8] Pilates in Juvenile Idiopathic Arthritis.
    不详
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S615 - S615
  • [9] Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis
    Trachana, M.
    Pratsidou-Gertsi, P.
    Pardalos, G.
    Kozeis, N.
    Badouraki, M.
    Kanakoudi-Tsakalidou, F.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2011, 40 (02) : 101 - 107
  • [10] The German etanercept registry for treatment of juvenile idiopathic arthritis.
    Horneff, G
    Biedermann, T
    Foeldvari, I
    Kuesters, RM
    Michels, H
    Moebius, D
    Schmeling, H
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S482 - S482